Drug Declaration

FCC ID: S6T561

Attestation Statements

Download: PDF
FCCID_1169703

REQUEST FOR CONFIDENTIALITY IN ACCORDANCE WITH FCC RULE 0.459 st 31 August 2009 TRaC Global 100 Frobisher Business Park Leigh Sinton Road Malvern Worcestershire WR14 1BX UK To Whom It May Concern: We certify that we are not subject to denial of federal benefits, that includes FCC benefits, pursuant to Section 5301 of the Anti-Drug Abuse ACT of 1988, U.S.C. 862. Further, no party, as defined in 47 CFR 1.2002(b), to the application, is subject to denial of federal benefits, that includes FCC benefits. Thank you for your attention to this matter. Thank you for your attention to these matters. Yours faithfully Tekelek Europe Ltd Martin Callanan Engineering Manager Tekelek Europe Ltd DIRECTORS: P. MC CARTHY (Managing), R. CULLEN. Registered in Ireland No. 232937 VAT Reg. IE8232937D WEEE Reg. 00232


Document Created: 2019-10-15 08:49:07
Document Modified: 2019-10-15 08:49:07
© 2024 FCC.report
This site is not affiliated with or endorsed by the FCC